Hygromycin B solution CAS: 31282-04-9
MF: C20H37N3O13
MW: 527.52

Hygromycin B solution (CAS 31282-04-9)

  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 128ms
  • REVIEWS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
Hygromycin B solution is rated 5.0 out of 5 by 4.
5
4
4
0
3
0
2
0
1
0
Noms alternatifs: Hygromycin B is also known as Hygrovetine and D-streptamine
Application: Hygromycin B solution is An antibiotic often used for selection of cells transfected with E. coli hygromycin resistance gene.
Numéro CAS: 31282-04-9
Pureté: >90%
Masse Moléculaire: 527.52
Formule Moléculaire: C20H37N3O13
Supplemental Information: This is classified as a Dangerous Good for transport and may be subject to additional shipping charges.
Pour la Recherche Uniquement. Non conforme pour le Diagnostic ou pour une Utilisation Thérapeutique.
* Consulter le Certificat d'Analyses pour les données spécifiques à un lot (incluant la teneur en eau).

Hygromycin B, which is also designated Hydrovetine and D-streptamine, is an aminoglycoside antibiotic substance naturally produced by Streptomyces hygroscopicus, which also shows anthelmintic activity. Hygromycin B has been shown to effectively inhibit translocation of mRNA and tRNAs on the ribosome in both bacteria and eukaryotes and also has a subtle effect on decoding fidelity as it slightly increases aminoacyl tRNA (A-site tRNA) affinity. Hygromycin B is suitable for the selection of cells transfected with Escherichia coli hygromycin resistance gene (hyg or hph), as well as for the maintenance of the Hygromycin phenotype of resistant cells. Consistent with its more specific effect on translocation, hygromycin B exhibits monophasic inhibition of polypeptide synthesis, suggesting that Hygromycin B binds to a single site on the ribosome. Other alternate designations for Hygromycin B include O-6-Amino-6-deoxy-L-glycero-D-galacto-heptopyranosylidene-(1→2-3)-O-β-D-talopyranosyl-(1→5)-2-deoxy-N3-methyl-D-streptamine; Antihelmycin; Hygromix 2.4; Hygromix-8 and Hygrovetin.


Références

1. González, A., et al. 1978. Biochim. Biophys. Acta. 521: 459-469. PMID: 367435

2. Rao, R.N., et al. 1983. Antimicrob. Agents Chemother. 24: 689-695. PMID: 6318654

3. Cullen, D., et al. 1987. Gene. 57: 21-26. PMID: 3322945

4. Perlin, D.S., et al. 1988. J. Biol. Chem. 263: 18118-18122. PMID: 3056938

5. Kronstad, J.W., et al. 1989. Gene. 79: 97-106. PMID: 2673937

6. Perlin, D.S., et al. 1989. J. Biol. Chem. 264: 21857-21864. PMID: 2532214

7. Egelhoff, T.T., et al. 1989. Mol. Cell. Biol. 9: 1965-1968. PMID: 2546056

8. Salauze, D., et al. 1990. Antimicrob. Agents Chemother. 34: 1915-1920. PMID: 1963287

9. Bilang, R., et al. 1991. Gene. 100: 247-250. PMID: 1647356

10. Dean, N., 1995. Proc. Natl. Acad. Sci. U.S.A. 92: 1287-1291. PMID: 7877969

Utilisation :
• This product is provided as 20 mL of a sterile filtered solution in PBS.


• Appearance: Solution color can vary from light yellow to a dark brown or caramel color. Concentrated Hygromycin solution tends to have a darker appearance.


• The working concentration for the purpose of selection varies with cell type, media, growth conditions and cell metabolic rate. A titration experiment for each cell type should be performed to determine the amount of Hygromycin B needed to kill non-transfected cells.


• Recommended concentrations for the selection of resistant cells is 25-1000 μg/ml. Commonly used concentrations for selection are 200 μg/ml for mammalian cells, 20-200 μg/ml for plant cells & bacteria cells and 200-1000 μg/ml for fungi. Your optimum concentration should be tested experimentally.


• Control cells should die within 5-7 days after addition of the antibiotic allowing colonies of resistant cells to form by 10–14 days.
Formulation :
50 mg/ml in PBS
État Physique :
Liquid
Dérivé de :
Streptomyces hygroscopicus
Solubilité :
Soluble in water, methanol, buffer solution, and ethanol.
STOCKAGE :
Store at 4° C
Pour la Recherche Uniquement. Non conforme pour le Diagnostic ou pour une Utilisation Thérapeutique.
RTECS :
WK2130000
PubChem CID :
35766
Index Merck :
14: 4852
Numéro MDL :
MFCD06795479
Numéro CE :
250-545-5

Télécharger la Fiche de Sécurité/ SDS (MSDS)

CERTIFICAT D'ANALYSE

Pour une bonne lecture, Adobe Acrobat Reader est requis,
imprimer et commenter les documents PDF

Hygromycin B solution (CAS 31282-04-9)  Références bibliographiques

Consultez les publications faisant référence à l' utilisation de Hygromycin B solution (CAS 31282-04-9). Cliquez sur le lien pour afficher lentrée PubMed .

Citations 1 à 10 sur un total de 28

PMID: # 30829571  Vallardi, G.|Allan, LA.|Crozier, L.|Saurin, AT.| et al. 2019. Elife. 8:

PMID: # 30838870  Wu, M.|Feng, Y.|Ye, GX.|Han, YC.|Wang, SS.|Ni, HF.|Wang, FM.|Gao, M.|Lv, LL.|Liu, BC.| et al. 2019. Am. J. Physiol. Renal Physiol. 316: F1006-F1015.

PMID: # 30881116  Chiang, KC.|Huang, ST.|Wu, RC.|Huang, SC.|Yeh, TS.|Chen, MH.|Hsu, JT.|Chen, LW.|Kuo, SF.|Chueh, HY.|Juang, HH.|Hung, SI.|Yeh, CN.|Pang, JS.| et al. 2019. Cancer Manag Res. 11: 1893-1905.

PMID: # 30034634  Barone, G.|Arora, A.|Ganesh, A.|Abdel-Fatah, T.|Moseley, P.|Ali, R.|Chan, SY.|Savva, C.|Schiavone, K.|Carmell, N.|Myers, KN.|Rakha, EA.|Madhusudan, S.|Collis, SJ.| et al. 2018. Oncotarget. 9: 29508-29524.

PMID: # 28674183  Paclíková, P. et al. 2017. Mol. Cell. Biol.

PMID: # 28870912  Pan, PJ. et al. 2017. Anticancer Res. 37: 4911-4918.

PMID: # 25271153  Kannike, K. et al. 2014. J. Biol. Chem. 289: 32845-57.

PMID: # 24606125  Eigler, T. et al. 2014. Mol. Endocrinol. 28: 554-64.

PMID: # 19468300  Wolfe, BA. et al. 2009. PLoS Biol. 7: -.

PMID: # 17362967  Laurentino, EC. et al. 2007. Int. J. Parasitol. 37: 735-742.

Citations 1 à 10 sur un total de 28
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 132ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 18ms
  • REVIEWS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;

Santa Cruz Biotechnology, Inc. est leader mondial dans le développement de produits pour la recherche biomédicale. Contactez-nous au 1-800-457-3801.
Copyright © 2007-2020 Santa Cruz Biotechnology, Inc. Tous Droits Réservés. "Santa Cruz Biotechnology", et le logo Santa Cruz Biotechnology, Inc., "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", le logo San Juan Ranch, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", et "EZ Touch" sont des marques déposées de Santa Cruz Biotechnology, Inc.
Toutes les marques sont la propriété de leurs propriétaires respectifs.